Anis Toumeh, MD(@AnisToumeh) 's Twitter Profile Photo

Protocol mandated dose reduction of does not compromise efficacy of adjuvant Abema in the trial. Reassuring for patients, and following a common theme in oral targeted therapies. OncoAlert

nature.com/articles/s4152…

account_circle
NCI Systems Biology(@NCIsysbio) 's Twitter Profile Photo

Dr. Russell Rockne (Russell Rockne) et al. City of Hope are developing experimental and computational tools to study altered immune signaling in . cancer.gov/about-nci/orga…

Dr. Russell Rockne (@rrockne) et al. @cityofhope #NCICSBC are developing experimental and computational tools to study altered immune signaling in #BreastCancer. cancer.gov/about-nci/orga… #BCSM
account_circle
Antonio Giordano, MD PhD(@antgiorda) 's Twitter Profile Photo

The limbo of having ER/PR low (<10%) is currently a very important problem for trial enrollment
ER 0 PR 5% HER2 0
1⃣cannot be enrolled in HR+ cohorts if have not received CDK4/6i
2⃣cannot be enrolled in TNBC cohort because ASCO/CAP guidelines
FDA Oncology relax I/E cr

account_circle
Stephanie Graff, MD, FACP, FASCO(@DrSGraff) 's Twitter Profile Photo

Getting excited for
Abstract titles are officially out 👀
conferences.asco.org/am/abstracts

And no surprise, for the reign of ADCs continues. At first glance, some anticipated results for Dato-DXd and T-DXd from Rebecca Shatsky, MD FabriceAndre and Sonia Pernas. 👏🏻

Getting excited for #ASCO24 
Abstract titles are officially out  👀
conferences.asco.org/am/abstracts

And no surprise, for #bcsm the reign of ADCs continues. At first glance, some anticipated results for Dato-DXd and T-DXd from @Dr_RShatsky @FAndreMD and @SoniaPernas. 👏🏻
account_circle
Yakup Ergün(@dr_yakupergun) 's Twitter Profile Photo

Breast cancer highlights from 2023: Knowledge to guide practice and future research

📌PubMed has 15,000 publications on BC in 2023.

The authors have summarized the most important studies

A great review👇

thebreastonline.com/article/S0960-…

Breast cancer highlights from 2023: Knowledge to guide practice and future research 

📌PubMed has 15,000 publications on BC in 2023. 

The authors have summarized the most important studies

A great review👇

#bcsm thebreastonline.com/article/S0960-…
account_circle
Dana Ataya MD(@DanaAtayaMD) 's Twitter Profile Photo

I’m going to the 2024 SBI Breast Imaging Symposium in Montreal this year and I’m bringing a guitar for the talent show! Come jam with me and let’s talk (and rock) breast cancer screening!

symposium 2024 screening

I’m going to the 2024 SBI Breast Imaging Symposium in Montreal this year and I’m bringing a guitar for the talent show! Come jam with me and let’s talk (and rock) breast cancer screening!

#sbi #sbisymposium #sbi2024 #breastcancerscreening #bcsm #breastcancer
account_circle
Aditya Bardia, MD(@dradityabardia) 's Twitter Profile Photo

Positive results from Destiny B06: T-DXd demonstrated PFS improvement over chemotherapy in the primary and overall trial population (incl HER2-low and ultralow). @oncoalert astrazeneca.com/media-centre/p…

account_circle